Neuronetrix Solutions, LLC

Neuronetrix Solutions, LLC is focused on developing advanced neurometric systems, with a strong emphasis on cognitive performance assessment through their flagship COGNISION® EEG/ERP system, serving a variety of healthcare and research clients. Neuronetrix Solutions, LLC was founded in 2004 and is headquartered in Louisville, US. The company specializes in neurometric systems, facilitating assessments of cognitive performance. In June 2018, Neuronetrix Solutions, LLC raised USD 2 million in venture funding, marking a significant investment for the firm.

The COGNISION® system has supported various clients in healthcare and research sectors to enhance their understanding of cognitive health. The firm has engaged in one total deal as of the latest funding round, which was the only amount raised, totaling USD 2 million. Cognision, a division of Neuronetrix Solutions, LLC, specializes in advanced neurometric systems centered around their flagship product, the COGNISION® EEG/ERP system. This scientifically validated technology facilitates cognitive performance assessments primarily in healthcare environments.

The system caters to physicians, pharmaceutical companies, and researchers, enhancing their understanding of neurological functions and cognitive health, with applications for clinical evaluations and pharmaceutical trials across North America and select international markets. Cognision's revenue model is structured around direct sales and partnerships with healthcare providers, pharmaceutical companies, and research institutions. Revenue is generated through one-time equipment purchases and ongoing support and training services. Contracts vary in scope and pricing, reflecting the specialized nature of cognitive assessment technologies in clinical and research settings, with tailored pricing plans based on client needs.

Looking ahead, Neuronetrix Solutions, LLC plans to expand its product offerings, focusing on upcoming enhancements to the COGNISION® system. The company aims to penetrate new markets, specifically targeting Europe and Asia by 2025. The recent funding of USD 2 million will be utilized to support these initiatives, including product development and market entry strategies, following their most recent investment in June 2018.